这是一篇来自已证抗体库的有关人类 IKKgamma的综述,是根据19篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合IKKgamma 抗体。
IKKgamma 同义词: AMCBX1; EDAID1; FIP-3; FIP3; Fip3p; IKK-gamma; IKKAP1; IKKG; IMD33; IP; IP1; IP2; IPD2; NEMO; ZC2HC9

圣克鲁斯生物技术
小鼠 单克隆(F-10)
  • 流式细胞仪; 人类; 图 6b
圣克鲁斯生物技术 IKKgamma抗体(Santa Cruz Biotechnology, F-10)被用于被用于流式细胞仪在人类样本上 (图 6b). Cell Mol Gastroenterol Hepatol (2021) ncbi
小鼠 单克隆
  • 流式细胞仪; 人类; 图 6b
圣克鲁斯生物技术 IKKgamma抗体(Santa Cruz Biotechnology, F-10)被用于被用于流式细胞仪在人类样本上 (图 6b). Cell Mol Gastroenterol Hepatol (2021) ncbi
小鼠 单克隆(B-3)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术 IKKgamma抗体(Santa Cruz, sc-8032)被用于被用于免疫印迹在人类样本上 (图 5). Oncotarget (2015) ncbi
小鼠 单克隆(B-3)
  • 免疫印迹; 人类
圣克鲁斯生物技术 IKKgamma抗体(Santa Cruz, sc-8032)被用于被用于免疫印迹在人类样本上. Mol Cell Biol (2013) ncbi
赛默飞世尔
小鼠 单克隆(72C627)
  • 免疫印迹; 小鼠; 1:1000; 图 5b
赛默飞世尔 IKKgamma抗体(Invitrogen, MA1-41046)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5b). Sci Signal (2019) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(EPR16629)
  • 免疫印迹; 小鼠; 1:5000; 图 7
艾博抗(上海)贸易有限公司 IKKgamma抗体(Abcam, ab178872)被用于被用于免疫印迹在小鼠样本上浓度为1:5000 (图 7). Anal Biochem (2016) ncbi
Active Motif
小鼠 单克隆(46B844)
  • 免疫印迹; 大鼠; 1:500
Active Motif IKKgamma抗体(Active Motif, 40908)被用于被用于免疫印迹在大鼠样本上浓度为1:500. J Cereb Blood Flow Metab (2003) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 s7e
赛信通(上海)生物试剂有限公司 IKKgamma抗体(Cell Signaling, 2685)被用于被用于免疫印迹在小鼠样本上 (图 s7e). Sci Adv (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 3f
赛信通(上海)生物试剂有限公司 IKKgamma抗体(CST, 2685)被用于被用于免疫印迹在小鼠样本上 (图 3f). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(DA10-12)
  • 免疫印迹; 人类; 图 3d
赛信通(上海)生物试剂有限公司 IKKgamma抗体(Cell Signaling, 2695)被用于被用于免疫印迹在人类样本上 (图 3d). PLoS Pathog (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 5b
赛信通(上海)生物试剂有限公司 IKKgamma抗体(Cell Signaling, 2685)被用于被用于免疫印迹在小鼠样本上 (图 5b). J Immunol (2016) ncbi
小鼠 单克隆(DA10-12)
  • 免疫印迹; 小鼠; 1:1000; 图 2
赛信通(上海)生物试剂有限公司 IKKgamma抗体(Cell Signaling, 2695)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2). PLoS ONE (2015) ncbi
小鼠 单克隆(DA10-12)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 IKKgamma抗体(CST, 2695S)被用于被用于免疫印迹在人类样本上. Oncotarget (2014) ncbi
小鼠 单克隆(DA10-12)
  • 免疫印迹基因敲除验证; 小鼠; 1 ug/ml; 图 1
赛信通(上海)生物试剂有限公司 IKKgamma抗体(Cell Signaling, DA10-12)被用于被用于免疫印迹基因敲除验证在小鼠样本上浓度为1 ug/ml (图 1). Nat Immunol (2007) ncbi
碧迪BD
小鼠 单克隆(54/IKK?/NEMO)
  • 免疫印迹基因敲除验证; 人类; 图 s4
  • 免疫细胞化学; 人类; 图 s1
碧迪BD IKKgamma抗体(BD Transduction Laboratories, 611306)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 s4) 和 被用于免疫细胞化学在人类样本上 (图 s1). Nat Commun (2016) ncbi
小鼠 单克隆(54/IKK?/NEMO)
  • 免疫印迹; 人类; 1:2000
碧迪BD IKKgamma抗体(BD Biosciences, 611306)被用于被用于免疫印迹在人类样本上浓度为1:2000. BMC Biol (2016) ncbi
小鼠 单克隆(54/IKK?/NEMO)
  • 免疫印迹; 人类; 图 3
碧迪BD IKKgamma抗体(BD, 611306)被用于被用于免疫印迹在人类样本上 (图 3). J Exp Med (2015) ncbi
小鼠 单克隆(54/IKK?/NEMO)
  • 免疫细胞化学; 人类
碧迪BD IKKgamma抗体(BD Transduction Laboratories, 611306)被用于被用于免疫细胞化学在人类样本上. J Virol (2013) ncbi
MBL International
  • 免疫印迹; 小鼠; 图 6a, 6e
MBL International IKKgamma抗体(MBL International, K0159-3)被用于被用于免疫印迹在小鼠样本上 (图 6a, 6e). Signal Transduct Target Ther (2021) ncbi
  • 免疫印迹; 人类; 1:1000; 图 s15
MBL International IKKgamma抗体(MBL, K0159-3)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s15). Nat Commun (2016) ncbi
文章列表
  1. Yu Z, Li X, Yang M, Huang J, Fang Q, Jia J, et al. TRIM41 is required to innate antiviral response by polyubiquitinating BCL10 and recruiting NEMO. Signal Transduct Target Ther. 2021;6:90 pubmed 出版商
  2. Sun R, Hedl M, Abraham C. TNFSF15 Promotes Antimicrobial Pathways in Human Macrophages and These Are Modulated by TNFSF15 Disease-Risk Variants. Cell Mol Gastroenterol Hepatol. 2021;11:249-272 pubmed 出版商
  3. Yang S, Harding A, Sweeney C, Miao D, Swan G, Zhou C, et al. Control of antiviral innate immune response by protein geranylgeranylation. Sci Adv. 2019;5:eaav7999 pubmed 出版商
  4. Herb M, Gluschko A, Wiegmann K, Farid A, Wolf A, Utermöhlen O, et al. Mitochondrial reactive oxygen species enable proinflammatory signaling through disulfide linkage of NEMO. Sci Signal. 2019;12: pubmed 出版商
  5. Wang H, Meng H, Li X, Zhu K, Dong K, Mookhtiar A, et al. PELI1 functions as a dual modulator of necroptosis and apoptosis by regulating ubiquitination of RIPK1 and mRNA levels of c-FLIP. Proc Natl Acad Sci U S A. 2017;114:11944-11949 pubmed 出版商
  6. Shibata Y, Tokunaga F, Goto E, Komatsu G, Gohda J, Saeki Y, et al. HTLV-1 Tax Induces Formation of the Active Macromolecular IKK Complex by Generating Lys63- and Met1-Linked Hybrid Polyubiquitin Chains. PLoS Pathog. 2017;13:e1006162 pubmed 出版商
  7. Scholefield J, Henriques R, Savulescu A, Fontan E, Boucharlat A, Laplantine E, et al. Super-resolution microscopy reveals a preformed NEMO lattice structure that is collapsed in incontinentia pigmenti. Nat Commun. 2016;7:12629 pubmed 出版商
  8. Nakazawa S, Oikawa D, Ishii R, Ayaki T, Takahashi H, Takeda H, et al. Linear ubiquitination is involved in the pathogenesis of optineurin-associated amyotrophic lateral sclerosis. Nat Commun. 2016;7:12547 pubmed 出版商
  9. Pourcelot M, Zemirli N, Silva da Costa L, Loyant R, Garcin D, Vitour D, et al. The Golgi apparatus acts as a platform for TBK1 activation after viral RNA sensing. BMC Biol. 2016;14:69 pubmed 出版商
  10. Naik E, Dixit V. Usp9X Is Required for Lymphocyte Activation and Homeostasis through Its Control of ZAP70 Ubiquitination and PKCβ Kinase Activity. J Immunol. 2016;196:3438-51 pubmed 出版商
  11. Maria Z, Campolo A, Lacombe V. Diabetes Alters the Expression and Translocation of the Insulin-Sensitive Glucose Transporters 4 and 8 in the Atria. PLoS ONE. 2015;10:e0146033 pubmed 出版商
  12. Spencer N, Yan Z, Cong L, Zhang Y, Engelhardt J, Stanton R. Definitive localization of intracellular proteins: Novel approach using CRISPR-Cas9 genome editing, with glucose 6-phosphate dehydrogenase as a model. Anal Biochem. 2016;494:55-67 pubmed 出版商
  13. Pulvino M, Chen L, Oleksyn D, Li J, Compitello G, Rossi R, et al. Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline. Oncotarget. 2015;6:14796-813 pubmed
  14. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939-51 pubmed 出版商
  15. Zhuang C, Sheng C, Shin W, Wu Y, Li J, Yao J, et al. A novel drug discovery strategy: mechanistic investigation of an enantiomeric antitumor agent targeting dual p53 and NF-κB pathways. Oncotarget. 2014;5:10830-9 pubmed
  16. Chan W, Schaffer T, Pomerantz J. A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival. Mol Cell Biol. 2013;33:429-43 pubmed 出版商
  17. Journo C, Bonnet A, Favre Bonvin A, Turpin J, Vinera J, C t E, et al. Human T cell leukemia virus type 2 tax-mediated NF-?B activation involves a mechanism independent of Tax conjugation to ubiquitin and SUMO. J Virol. 2013;87:1123-36 pubmed 出版商
  18. Zhao T, Yang L, Sun Q, Arguello M, Ballard D, Hiscott J, et al. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat Immunol. 2007;8:592-600 pubmed
  19. Han H, Karabiyikoglu M, Kelly S, Sobel R, Yenari M. Mild hypothermia inhibits nuclear factor-kappaB translocation in experimental stroke. J Cereb Blood Flow Metab. 2003;23:589-98 pubmed